Institute for Peptide Therapy

Peptides are an
Emerging
Therapeutic Modality.

The Institute for Peptide Therapy is an emerging U.S. body convening clinicians, researchers and educators around peer exchange, professional education, clinical governance and the future of therapeutics. It will support the forthcoming Journal for Peptide Therapy, a monthly publication addressing clinically relevant advances from around the world.

Headquarters

United States

Founders

Christopher Maclay, MD (Retired) & Tony Leto, JD

Status

In formation

Our remit

Five quiet commitments that will shape the Institute’s early work.

  • 01

    Peer exchange

    A considered space for clinicians and researchers to convene, compare practice and learn from one another.

  • 02

    Professional education

    Structured learning resources and continuing professional development for qualified practitioners.

  • 03

    Clinical governance

    Frameworks, standards and reflective tools that support safe, accountable and ethical practice.

  • 04

    Research

    Curating literature, supporting investigators and convening dialogue around emerging evidence.

  • 05

    Future of therapeutics

    A long-view forum for the scientific, regulatory and societal questions shaping the field.

  • 06

    The Journal

    A monthly editorial review of clinically relevant developments in peptide therapy, published under the Institute.

Education pathway

Learn. Think. Apply.

A structured postgraduate education pathway in therapeutic peptides, for healthcare professionals seeking an evidence-based understanding of one of the fastest-evolving areas of modern medicine. Programmes are organised around professional development — scientific integrity, clinical reasoning and the responsible governance of emerging therapies — rather than around individual compounds.

All programmes are delivered in English and suitable for an international audience. Additional language editions may follow.

Foundation programmes
Clinical domain certificates
Advanced & continuing education

Educational philosophy

Scientific integrity

Presenting evidence honestly, including its strengths and limitations.

Clinical reasoning

Developing structured approaches to evaluating emerging therapies.

Patient safety

Emphasising governance, ethics and responsible professional practice.

Lifelong learning

Peptide science continues to evolve and requires continual critical appraisal.

Our programmes are educational in nature. They are designed to strengthen scientific understanding, clinical reasoning and professional governance. They do not provide prescribing advice, do not recommend any specific drug, biologic or dietary supplement, and do not constitute training in the administration of any therapy. Clinical decisions remain the responsibility of individual U.S.-licensed practitioners operating within their state scope of practice and applicable federal and state law. See our full regulatory disclaimer.

Enquiries

Contact the Institute

For professional, educational, editorial or research enquiries, please use the form below. See our regulatory disclaimer for the scope of information published here.

Enquiries are for professional and educational correspondence only. Please do not include patient-identifiable information or requests for medical advice.